529 related articles for article (PubMed ID: 2959468)
1. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels.
Autelitano DJ; Clements JA; Nikolaidis I; Canny BJ; Funder JW
Endocrinology; 1987 Nov; 121(5):1689-96. PubMed ID: 2959468
[TBL] [Abstract][Full Text] [Related]
2. Concomitant up-regulation of proopiomelanocortin and dopamine D2-receptor gene expression in the pituitary intermediate lobe of the spontaneously hypertensive rat.
Autelitano DJ; van den Buuse M
J Neuroendocrinol; 1997 Apr; 9(4):255-62. PubMed ID: 9147288
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid regulation of proopiomelanocortin gene expression in the pituitary gland of hypothalamopituitary intact and hypothalamopituitary disconnected sheep.
Mercer JE; Clements JA; Clarke IJ; Funder JW
Neuroendocrinology; 1989 Sep; 50(3):280-5. PubMed ID: 2797383
[TBL] [Abstract][Full Text] [Related]
4. Chronic haloperidol treatment increases the level of in vitro translatable messenger ribonucleic acid coding for the beta-endorphin/adrenocorticotropin precursor proopiomelanocortin in the pars intermedia of the rat pituitary.
Höllt V; Haarmann I; Seizinger BR; Herz A
Endocrinology; 1982 Jun; 110(6):1885-91. PubMed ID: 6280978
[TBL] [Abstract][Full Text] [Related]
5. Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis, and plasma beta-endorphin levels in the rat.
Dave JR; Eiden LE; Karanian JW; Eskay RL
Endocrinology; 1986 Jan; 118(1):280-6. PubMed ID: 2934242
[TBL] [Abstract][Full Text] [Related]
6. Onset of glucocorticoid responsiveness of anterior pituitary corticotrophs during development is scheduled by corticotropin-releasing factor.
Grino M; Burgunder JM; Eskay RL; Eiden LE
Endocrinology; 1989 Jun; 124(6):2686-92. PubMed ID: 2524376
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid and glucocorticoid effects on 31,000- and 29,000-dalton proopiomelanocortin in rat anterior pituitary and neurointermediate lobe.
Khalid BA; Lim AT; Fraillon DR; Funder JW
J Clin Invest; 1982 Aug; 70(2):443-52. PubMed ID: 6284802
[TBL] [Abstract][Full Text] [Related]
8. Post-translational processing of pro-opiomelanocortin in the Brattleboro (di/di) rat pituitary.
Canny BJ; Smith AI; Clements JA; Funder JW
Neuroendocrinology; 1988 Dec; 48(6):603-10. PubMed ID: 2855104
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic mediation of physiological changes in proopiomelanocortin messenger ribonucleic acid expression in the neurointermediate lobe of the rat pituitary.
Pardy K; Carter D; Murphy D
Endocrinology; 1990 Jun; 126(6):2960-4. PubMed ID: 2161741
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids potentiate the adenylyl cyclase-cAMP system mediated immunoreactive beta-endorphin production and secretion from hypothalamic neurons in culture.
Yang Z; Lee D; Huang W; Copolov DL; Lim AT
Brain Res; 1994 Jun; 648(1):99-108. PubMed ID: 7522925
[TBL] [Abstract][Full Text] [Related]
11. Coordinate regulation of peptide acetyltransferase activity and proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary.
Millington WR; O'Donohue TL; Chappell MC; Roberts JL; Mueller GP
Endocrinology; 1986 May; 118(5):2024-33. PubMed ID: 2938933
[TBL] [Abstract][Full Text] [Related]
12. Neurotransmitters and estrogen interact to affect beta-endorphin levels in castrated female rats.
Forman LJ; Estilow S
Peptides; 1986; 7(5):775-81. PubMed ID: 2948165
[TBL] [Abstract][Full Text] [Related]
13. Developmental regulation of proopiomelanocortin gene expression in the fetal and neonatal rat pituitary.
Scott RE; Pintar JE
Mol Endocrinol; 1993 Apr; 7(4):585-96. PubMed ID: 8502239
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe.
Lamberts SW; Uitterlinden P; Bons EG; Zuiderwijk JM; Verleun T; Oosterom R; Hackeng WH
Endocrinology; 1984 Jun; 114(6):2349-53. PubMed ID: 6327244
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the expression and secretion of urocortin 2 in rat pituitary.
Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T
J Endocrinol; 2007 Feb; 192(2):443-52. PubMed ID: 17283244
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid regulation of proopiomelanocortin messenger ribonucleic acid content of rat hypothalamus.
Beaulieu S; Gagné B; Barden N
Mol Endocrinol; 1988 Aug; 2(8):727-31. PubMed ID: 3211157
[TBL] [Abstract][Full Text] [Related]
17. Regulation of proopiomelanocortin gene expression in rat brain and pituitary as studied by in situ hybridization.
Pelletier G
Ann N Y Acad Sci; 1993 May; 680():246-59. PubMed ID: 8512219
[TBL] [Abstract][Full Text] [Related]
18. Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitary.
Höllt V; Przewłocki R; Haarmann I; Almeida OF; Kley N; Millan MJ; Herz A
Neuroendocrinology; 1986; 43(3):277-82. PubMed ID: 2942792
[TBL] [Abstract][Full Text] [Related]
19. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats.
Jingami H; Matsukura S; Numa S; Imura H
Endocrinology; 1985 Oct; 117(4):1314-20. PubMed ID: 2992910
[TBL] [Abstract][Full Text] [Related]
20. Beta-endorphin inhibits hypoglycemia-induced gene expression of corticotropin-releasing factor in the rat hypothalamus.
Suda T; Sato Y; Sumitomo T; Nakano Y; Tozawa F; Iwai I; Yamada M; Demura H
Endocrinology; 1992 Mar; 130(3):1325-30. PubMed ID: 1311237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
